Who owns COEPTIS THERAPEUTICS HLDGS I?

Tip: Access positions for across all investors

Analyze quarterly positions in Coeptis Therapeutics Hldgs I with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Coeptis Therapeutics Hldgs I stock

Who bought or sold COEPTIS THERAPEUTICS HLDGS I this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 340k $4.8M 570% Dec 2025
 View chart
Geode Capital Management 42k $601k 13% Dec 2025
 View chart
State Street Corporation 27k $382k 35% Dec 2025
 View chart
Marshall Wace 18k $259k 100% Dec 2025
 View chart
BlackRock 14k $193k 100% Dec 2025
 View chart
Northern Trust 12k $174k 100% Dec 2025
 View chart
Steward Partners Investment Advisory 5.0k $71k 100% Dec 2025
 View chart
Pnc Financial Services 238.00 $3.4k -49% Dec 2025
 View chart
UBS Group 193.00 $2.7k 100% Dec 2025
 View chart
Advisor Group Holdings 100.00 $1.4k 100% Dec 2025
 View chart
SageView Advisory Group 3.00 $42.999900 100% Dec 2025
 View chart
Barclays 3.00 $42.999900 0% Dec 2025
 View chart

Who sold out of Coeptis Therapeutics Hldgs I?

Fund or Company Name Date Sold Shares Held Valued At
Renaissance Technologies Sep 2025 19k $323k
Yorkville Advisors Global Sep 2025 8.0k $140k